Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: A challenge for couples with hereditary breast and ovarian cancer

Human Reproduction

Volumn 29, Issue 5, 2014, Pages 1103-1112

  Derks Smeets, I A P ^a,b   Gietel Habets, J J G ^a   Tibben, A ^c   Tjan Heijnen, V C G ^a,b   Meijer Hoogeveen, M ^d   Geraedts, J P M ^a,b   Van Golde, R ^a   Gomez Garcia, E ^a,b   Van Den Bogaart, E ^e   Van Hooijdonk, M ^e   De Die Smulders, C E M ^a,b   Van Osch, L A D M ^a,e  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^e MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

BRCA1 2; hereditary breast and ovarian cancer syndrome; preimplantation genetic diagnosis; prenatal diagnosis; reproductive decision making

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ADULT; ARTICLE; CANCER RISK; CANCER SURVIVOR; CLINICAL ARTICLE; CONCEPTION; DECISION SUPPORT SYSTEM; DISEASE SEVERITY; EXPLORATORY RESEARCH; FAMILIAL CANCER; FEMALE; FERTILIZATION IN VITRO; GENE MUTATION; GENETIC COUNSELING; GENETIC PROCEDURES; HEREDITARY BREAST AND OVARIAN CANCER SYNDROME; HIGH RISK PATIENT; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LIVE BIRTH; MALE; MEDICAL HISTORY; PATIENT DECISION MAKING; PERSONAL EXPERIENCE; PRACTICE GUIDELINE; PREGNANCY TERMINATION; PREIMPLANTATION GENETIC DIAGNOSIS; PRENATAL DIAGNOSIS; QUALITATIVE RESEARCH; BREAST TUMOR; DECISION MAKING; GENETIC SCREENING; GENETICS; MUTATION; OVARY TUMOR; PREGNANCY; TUMOR SUPPRESSOR GENE; YOUNG ADULT;

ADULT; BREAST NEOPLASMS; DECISION MAKING; FEMALE; GENES, BRCA1; GENETIC TESTING; HUMANS; MUTATION; OVARIAN NEOPLASMS; PREGNANCY; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; YOUNG ADULT;

EID: 84898895865     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu034     Document Type: Article

References (43)

1. Barnett T. Dimensions of moral intensity and ethical decision making: an empirical study. J Appl Soc Psychol 2001;31:1038-1057.
2. Braga C, Negri E, la Vecchia C, Parazzini F, Dal Maso L, Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod 1996;11:300-303.
3. Bray F, Mc Carron P, Parkin DM. The changing global patternsoffemale breast cancer incidence and mortality. Breast Cancer Res 2004;6:229-239.
4. Chamayou S, Guglielmino A, Giambona A, Siciliano S, Di Stefano G, Scibilia G, Humeau C, Maggio A, Di Leo S. Attitude of potential users in Sicily towards preimplantation genetic diagnosis for beta-thalassaemia and aneuploidies. Hum Reprod 1998;13:1936-1944.
5. Chen S, Parmigiani G. Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 2007;25:1329-1333.
6. Cullinane CA, Lubinski J, Neuhausen SL, Ghadirian P, Lynch HT, Isaacs C, Weber B, Moller P, Offit K, Kim-Sing C et al. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers. Int J Cancer 2005;117:988-991.
7. Dekeuwer C, Bateman S. Much more than a gene: hereditary breast and ovarian cancer, reproductive choices and family life. Med Health Care Philos 2013;16:231-244.
8. Domchek SM, Friebel TM, Singer CF, Evans DG, Lynch HT, Isaacs C, Garber JE, Neuhausen SL, Matloff E, Eeles R et al. Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 2010;304:967-975.
9. Donnelly LS, Watson M, Moynihan C, Bancroft E, Evans DG, Eeles R, Lavery S, Ormondroyd E. Reproductive decision-making in young female carriers of a BRCA mutation. Hum Reprod 2013;28:1006-1012.
10. Ferraretti AP, Goossens V, deMouzon J, Bhattacharya S, Castilla JA, Korsak V, Kupka M, Nygren KG, Nyboe Andersen A. Assisted reproductive technology in Europe, 2008: results generated from European registers by ESHRE. Hum Reprod 2012;27:2571-2584.
11. Gauthier E, Paoletti X, Clavel-Chapelon F. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 2004;19:2216-2221.
12. Glaser BG, Strauss AL. The Discovery of Grounded Theory: Strategies for Qualitative Research. Transaction Books, New Jersey, 2009.
13. Hallowell N, Arden-Jones A, Eeles R, Foster C, Lucassen A, Moynihan C, Watson M. Guilt, blame and responsibility: men's understanding of their role in the transmission of BRCA1/2 mutations within their family. Sociol Health Illn 2006;28:969-988.
14. Hershberger PE, Pierce PF. Conceptualizing couples' decision making in PGD: emerging cognitive, emotional, and moral dimensions. Patient Educ Couns 2010;81:53-62.
15. Hurley K, Rubin LR, Werner-Lin A, Sagi M, Kemel Y, Stern R, Phillips A, Cholst I, Kauff N, Offit K. Incorporating information regarding preimplantation genetic diagnosis into discussions concerning testing and risk management for BRCA1/2 mutations: a qualitative study of patient preferences. Cancer 2012;118:6270-6277.
16. James CA, Hadley DW, Holtzman NA, Winkelstein JA. How does the mode of inheritance of a genetic condition influence families? A study of guilt, blame, stigma, and understanding of inheritance and reproductive risks in families with X-linked and autosomal recessive diseases. Genet Med 2006;8:234-242.
17. Julian-Reynier C, Fabre R, Coupier I, Stoppa-Lyonnet D, Lasset C, Caron O, Mouret-Fourme E, Berthet P, Faivre L, Frenay M et al. BRCA1/2 carriers: their childbearing plans and theoretical intentions about having preimplantation genetic diagnosis and prenatal diagnosis. Genet Med 2012;14:527-534.
18. Kalfoglou AL, Scott J, Hudson K. PGD patients' and providers' attitudestothe use and regulation of preimplantation genetic diagnosis. Reprod Biomed Online 2005;11:486-496.
19. Kiemeney LA, Lemmers FA, Verhoeven RH, Aben KK, Honing C, de Nooijer J, Peeters PH, Visser O, Vlems FA. The risk of cancer in the Netherlands. Ned Tijdschr Geneeskd 2008;152:2233-2241.
20. Klip H, Burger CW, Kenemans P, van Leeuwen FE. Cancer risk associated with subfertility and ovulation induction: a review. Cancer Causes Control 2000;11:319-344.
21. Kotsopoulos J, Librach CL, Lubinski J, Gronwald J, Kim-Sing C, Ghadirian P, Lynch HT, Moller P, Foulkes WD, Randall S et al. Infertility, treatment of infertility, and the risk of breast cancer among women with BRCA1 and BRCA2 mutations: a case-control study. Cancer Causes Control 2008; 19:1111-1119.
22. Lavery SA, Aurell R, Turner C, Castello C, Veiga A, Barri PN, Winston RM. Preimplantation genetic diagnosis: patients' experiences and attitudes. Hum Reprod 2002;17:2464-2467.
23. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JG, Niermeijer MF. Attitudes towards termination of pregnancy in subjects who underwent presymptomatic testing for the BRCA1/BRCA2 gene mutation in The Netherlands. J Med Genet 2000; 37:883-884.
24. Menon U, Harper J, Sharma A, Fraser L, Burnell M, El Masry K, Rodeck C, Jacobs I. Views of BRCA gene mutation carriers on preimplantation genetic diagnosis as a reproductive option for hereditary breast and ovarian cancer. Hum Reprod 2007;22:1573-1577.
25. Morgan DL, Krueger R. The Focus Group Guidebook. Thousand Oaks, CA, USA: SAGE Publications, 1998.
26. Ormondroyd E, Donnelly L, Moynihan C, Savona C, Bancroft E, Evans DG, Eeles R, Lavery S, Watson M. Attitudes to reproductive genetic testing in women who had a positive BRCA test before having children: a qualitative analysis. Eur J Hum Genet 2012;20:4-10.
27. Pope C, van Royen P, Baker R. Qualitative methodsinresearchonhealthcare quality. Qual Saf Health Care 2002;11:148-152.
28. Quinn G, Vadaparampil S, Wilson C, King L, Choi J, Miree C, Friedman S. Attitudes of high-risk women toward preimplantation genetic diagnosis. Fertil Steril 2009;91:2361-2368.
29. Quinn GP, Vadaparampil ST, Tollin S, Miree CA, Murphy D, Bower B, Silva C. BRCA carriers' thoughts on risk management inrelation to preimplantation genetic diagnosis andchildbearing: whentoo manychoicesare justasdifficult as none. Fertil Steril 2010a;94:2473-2475.
30. Quinn GP, Vadaparampil ST, Miree CA, Lee JH, Zhao X, Friedman S, Yi S, Mayer J. High risk men's perceptions of pre-implantation genetic diagnosis for hereditary breast and ovarian cancer. Hum Reprod 2010b; 25:2543-2550.
31. Quinn GP, Pal T, Murphy D, Vadaparampil ST, Kumar A. High-risk consumers' perceptions of preimplantation genetic diagnosis for hereditary cancers: a systematic review and meta-analysis. Genet Med 2012;14:191-200.
32. Roberts C, Franklin S. Experiencing new forms of genetic choice: findings from an ethnographic study of preimplantation genetic diagnosis. Hum Fertil (Camb) 2004;7:285-293.
33. Sagi M, Weinberg N, Eilat A, Eizenman E, Werner M, Girsch E, Siminovsky Y, Abeliovich D, Peretz T, Simon A et al. Preimplantation genetic diagnosis for BRCA1/2-a novel clinical experience. Prenat Diagn 2009;29:508-513.
34. Salhab M, Al Sarakbi W, Mokbel K. Invitro fertilization andbreast cancerrisk: a review. Int J Fertil Womens Med 2005;50:259-266.
35. Shenfield F, Pennings G, Devroey P, Sureau C, Tarlatzis B, Cohen J. Taskforce 5: preimplantation genetic diagnosis. Hum Reprod 2003;18:649-651.
36. Snowdon C, Green JM. Preimplantation diagnosis and other reproductive options: attitudes of male and female carriers of recessive disorders. Hum Reprod 1997;12:341-350.
37. Staton AD, Kurian AW, Cobb K, Mills MA, Ford JM. Cancer risk reduction and reproductive concerns in female BRCA1/2 mutation carriers. Fam Cancer 2008;7:179-186.
38. Szabo C, Masiello A, Ryan JF. The breast cancer information core: database design, structure and scope. Hum Mutat 2000;16:123-131.
39. Thornhill AR, de Die-Smulders CE, Geraedts JP, Harper JC, Harton GL, Lavery SA, Moutou C, Robinson MD, Schmutzler AG, Scriven PN et al. ESHRE PGD Consortium 'Best practice guidelines for clinical preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS)'. Hum Reprod 2005;20:35-48.
40. van Rij MC, Gielen M, Lulofs R, Evers JL, van Osch L, Muntjewerff N, Geraedts JP, de Die-Smulders CE. Profiles and motives for PGD: a prospective cohort study of couples referred for PGD in the Netherlands. Hum Reprod 2011;26:1826-1835.
41. Venn A, Healy D, Mc Lachlan R. Cancer risks associated with the diagnosis of infertility. Best Pract Res Clin Obstet Gynaecol 2003;17:343-367.
42. Wagner TM, Ahner R. Prenatal testing for late-onset diseases such as mutations in the breast cancer gene 1 (BRCA1). Just a choice or a step in the wrong direction? Hum Reprod 1998;13:1125-1126.
43. Werner-Lin A, Rubin LR, Doyle M, Stern R, Savin K, Hurley K, Sagi M. 'My funky genetics': BRCA1/2 mutation carriers' understanding of genetic inheritance and reproductive merger in the context of new reprogenetic technologies. Fam Syst Health 2012;30:166-180.